Clinical Trial Update: Naloxone Methadone Combination (NAMEKO) [NA]

View source ↗

Summary

A clinical trial evaluating a naloxone-methadone combination (NAMEKO) for opioid dependence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Methadone (methadone)
• Naloxone (Naloxone)

Snippet

Sponsor: Kuopio University Hospital | Conditions: Opiate Dependence | NA | Status: WITHDRAWN